Role of novel mediators of inflammation in left ventricular remodeling in patients with acute myocardial infarction: Do they affect the outcome of patients?

Angiology

Volumn 58, Issue 1, 2007, Pages 45-54

  Oren, Hüseyin ^a,c   Erbay, A Riza ^a   Balci, Mustafa ^a   Çehreli, Sengül ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 3;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; DISEASE SEVERITY; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HUMAN; IMMUNOPHELOMETRY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THORAX PAIN;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FIBRINOGEN; HUMANS; INTERLEUKIN-3; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33847045891     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706297916     Document Type: Article

References (45)

1. Jugdutt BI: Prevention of ventricular remodelling post-myocardial infarction: Timing and duration of therapy. Can J Cardiol 9: 103-114, 1993.
2. Frangogiannis NG, Smith CW, Entman ML: Review. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
3. Cannon CP, Weintraub WS, Demopoulos LA, et al: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344: 1879-1887, 2001.
4. Ridker PM, Buring JE, Shih J, et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733, 1998.
5. Furman MI, Becker RC, Yarzebski J, et al: Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 78: 945-948, 1996.
6. Cannon CP, McCabe CH, Wilcox RG, et al, for the OPUS-TIMI-16 investigators: Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 87: 636-639, 2001.
7. Maekawa Y, Anzai T, Yoshikawa, et al: Prognostic significance of peripheral monocytosis after reper-fused acute myocardial infarction: A possible role for left ventricular remodeling. J Am Coll Cardiol 39: 241-246, 2002.
8. Dubay DA, Franz MG: Acute wound healing: The biology of acute wound failure. Surg Clin North Am 83: 463-481, 2003.
9. Robson MC: Proliferative scarring. Surg Clin North Am 83: 557-569, 2003.
10. Thomson A: Interleukins. In: The Cytokine Handbook, ed. 3, ed. by Oppenheim JJ. San Diego: Academic Press, 1998, pp 146-162.
11. Henry G, Garner WL: Inflammatory mediators in wound healing. Surg Clin North Am 83: 483-507, 2003.
12. Entman ML, Smith CW: Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease. Cardiovasc Res 9: 1301-1311, 1994.
13. Frangogiannis NG, Youker KA, Rossen RD, et al: Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol 12: 2567-2576, 1998.
14. Frangogiannis NG, Entman ML: Role of inflammation following myocardial ischemia and reperfusion. In: Textbook of Coronary Thrombosis and Thrombolysis, ed. by Becker RC. Dordrecht: Kluwer Academic, 1997, pp 569-584.
15. Mehta JL, Li DY: Inflammation in ischemic heart disease: Response to tissue injury or a pathogenetic villain ? Cardiovasc Res 2: 291-299, 1999.
16. Rossen RD, Michael LH, Hawkins HK, et al: Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ Res 3: 546-555, 1994.
17. Vakeva AP, Agah A, Rollins SA, et al: Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 22: 2259-2267, 1998.
18. Yasojima K, Kilgore KS, Washington RA, et al: Complement gene expression by rabbit heart: Upregulation by ischemia and reperfusion. Circ Res 11: 1224-1230, 1998.
19. Jordan JE, Zhao ZQ, Vinten-Johansen J: The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
20. Engler RL: Free radical and granulocyte-mediated injury during myocardial ischemia and reperfusion. Am J Cardiol 10: 19E - 23E, 1989.
21. Lasky LA: Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 258: 964-969, 1999.
22. Ebnet K, Vestweber D: Molecular mechanisms that control leukocyte extravasation: The selectins and the chemokines. Histochem Cell Biol 1: 1-23, 1999.
23. Litt MR, Jeremy RW, Weisman HF, et al: Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 6: 1816-1827, 1989.
24. Lefer DJ, Granger DN: Oxidative stress and cardiac disease. Am J Med 4: 315-323, 2000.
25. Dhalla NS, Elmoselhi AB, Hata T, et al: Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 3: 446-456, 2000.
26. De Beer FC, Hind CR, Fox KM, et al: Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J 47: 239-243, 1982.
27. Kushner I, Broder ML, Karp D: Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 61: 235-242, 1978.
28. Pietila K, Hermens WT, Harmoinen A, et al: Comparison of peak serum C-reactive protein and hydroxy-butyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase. Am J Cardiol 80: 1075-1077, 1997.
29. Tommasi S, Carluccio E, Bentivoglio M, et al: C-re-active protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 83: 1595-1599, 1999.
30. Takahashi T, Anzai T, Yoshikawa T, et al: Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction - role of neurohormones and cytokines. Int J Cardiol 88: 257-265, 2003.
31. Matsumori A, Yamada T, Suzuki H, et al: Increased circulating cytokines in patients with myocarditis cardiomyopathy. Br Heart J 72: 561-566, 1994.
32. Tashiro H, Shimokawa H, Yamamoto K, et al: Monocyte-related cytokines in acute myocardial infarction. Am Heart J 130: 446-452, 1995.
33. Kurosaki K, Ikeda U, Murakami Y, et al: Inhibition of the renin-angiotensin system: No effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction. J Cardiovasc Pharmacol 42: 37-41, 2003.
34. Rosenfeld ME, Yla-Herttuala S, Lipton BA, et al: Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 140: 291-300, 1992.
35. Clinton SK, Underwood R, Hayes L, et al: Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 140: 301-316, 1992.
36. Factor SM, Bache RJ: Pathophysiology of myocardial ischemia. In: The Heart, Arteries and Veins, ed. by Schlant RC, Alexander RW. New York: McGraw-Hill, 1994, pp 1033-1053.
37. Arai K, Lee F, Miyajima A, et al: Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783-836, 1990.
38. Brizzi MF, Garbarino G, Rossi PR, et al: Interleukin-3 stimulates proliferation and triggers endothelialleukocyte adhesion molecule 1 gene activation of human endothelial cells. J Clin Invest 91: 2887-2892, 1993.
39. Wimperis JZ, Niemeyer CM, Sieff CA, et al: Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNA are produced by a small fraction of blood mononuclear cells. Blood 74: 1525-1530, 1989.
40. Wodnar-Filipowicz A, Heusser CH, Moroni C: Production of the hematopoietic growth factors GM-CSF and IL-3 by mast cell in response to Ig E receptor-mediated activation. Nature (London) 339: 150-152, 1989.
41. Razin E, Leslie K, Schrader JW: Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction. J Immunol 146: 981-987, 1991.
42. Weihrauch D, Arras M, Zimmermann R, et al: Importance of monocytes/macrophages and fibroblasts for healing of micronecroses in porcine myocardium. Mol Cell Biochem 1-2: 13-19, 1995.
43. Frangogiannis NG, Perrard JL, Mendoza LH, et al: Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 7: 687-698, 1998.
44. Belosjorow S, Schulz R, Dorge H, et al: Endotoxin and ischemic preconditioning: TNF-α concentration and myocardial infarct development in rabbits. Am J Physiol 6: H2470 - H2475, 1999.
45. Tilg H, Mair J, Herold M, et al: Acute phase response after myocardial infarction: Correlation between serum levels of cytokines and C-reactive protein. Klin Wochenschr 68: 1083-1083, 1990.